The company announced the appointment of Umesh Kunte as the chief executive officer (CEO) with effect from 6 February 2023.
Albert David also appointed A B Chakrabartty as the company secretary & compliance officer cum legal head of the company with effect from 4 February 2023.Kolkata-based Albert David is a pharmaceutical company. Its net profit rose 58.96% to Rs 20.14 crore on 7% rise in net sales to Rs 92.38 crore in Q2 September 2022 over Q2 September 2021.
Shares of Albert David ended flat at Rs 550 on Friday, 3 February 2023.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
